RHMS TournayService de néphrologie
About RHMS TournayService de néphrologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at RHMS TournayService de néphrologie
During the past decade, RHMS TournayService de néphrologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
2000-10-01
Unknown status
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
2002-06-01
Unknown status
Determination of Carboplatin's Optimal Plasmatic Exposure
2005-05-01
2009-02-01
Completed
400
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer
2005-09-01
Completed
835
Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)
2009-01-01
2018-07-01
Terminated
335
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
2010-04-01
2014-12-01
Completed
183
Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
2011-10-01
2014-02-01
Completed
2,114
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "RHMS TournayService de néphrologie"
#1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at RHMS TournayService de néphrologie
According to Clinical.Site data, the most researched conditions in "RHMS TournayService de néphrologie" are
"Hepatitis B" (4 trials). Many other conditions were trialed in "RHMS TournayService de néphrologie" in a lesser frequency.
Clinical Trials Intervention Types at RHMS TournayService de néphrologie
Most popular intervention types in "RHMS TournayService de néphrologie" are "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "HBVAXPRO vaccine" (2 trials), "FENDRIX" (1 trials), "Fendrix vaccine" (1 trials), "HB-AS02V" (1 trials) and "HB-AS02V vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at RHMS TournayService de néphrologie
The vast majority of trials in "RHMS TournayService de néphrologie" are
4 trials for "All" genders.
Clinical Trials Status at RHMS TournayService de néphrologie
Currently, there are NaN active trials in "RHMS TournayService de néphrologie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in RHMS TournayService de néphrologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in RHMS TournayService de néphrologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".